Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | 1₹1.9 LAccepted-AOC | ₹1.9 L Quoted ₹13.91 | 1 | Accepted-AOC SUITABLE OFFER |
| 2 | 2₹14.50+₹0.59 (4.24%)Rejected-AOC PLOT NO C 20 1 C 21 PHASE III MIDC AKOLA AKOLA MAHARASHTRA 444104 | AKOLA | MAHARASHTRA | 444104 | ₹14.50+₹0.59 (4.24%) | 2 | Rejected-AOC HIGHER RATE OFFERED |
| Sl No | Description | Qty | Unit | SHRIVINAYAKPHARMA L1 | LEBEN LIFE SCIENCES PVT LTD L2 |
|---|---|---|---|---|---|
| 0.00Items : | |||||
| 1.00 | Ointment Diclofenac + Methyl Salicylic + Linsed + Menthol (each tube of 30 gm.) | 14,000 | Tubes | 1,94,740 ₹1,94,740 Lowest | 2,02,860 ₹2,02,860 |
Tender Value
Refer Docs
Closing Date
9 Mar 2026, 4:00 pmClosed
DMM(T-II)
DADAR
Ointment Diclofenac plus Methyl Salicylic plus Linseed plus Menthol
2025_BEST_1247042_2
DMM/GEN/04/80974/757/2025-26/C
Open Tender
Medicines
Item Wise
365 days
DADAR
AS PER ATTACHED DOCUMENTS.
6 documents required · 6 mandatory
₹0
Exempted
27 Apr 2026
24 Feb 2026
11 Mar 2026
24 Feb 2026
9 Mar 2026
24 Feb 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 0 | Items : | - | - | - | - |
| 1 | Ointment Diclofenac + Methyl Salicylic + Linsed + Menthol (each tube of 30 gm.) | 14,000 | Tubes | - | - |
stage.html
html • 0.04 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
aoc.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.04 MB
CredintialForm.pdf
PDF • 0.05 MB
COTCOS.pdf
PDF • 1.88 MB
ProcurementGuidelines2015.pdf
PDF • 0.17 MB
RevisedProcGuidelines2023.pdf
PDF • 0.36 MB
SCHI80974.pdf
Tender Documents • 0.07 MB
BOQ_2203724.xls
BOQ • 0.29 MB
80974_PP.pdf
PDF • 0.31 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .